Beijing Institute of Biotechnology Team Links miR-148a to HBV-Associated Cancer | GenomeWeb

Researchers from the Beijing Institute of Biotechnology this week published research suggesting that the suppression of a specific microRNA by the hepatitis B virus is responsible for the cancer growth and metastasis that is sometimes caused by the infection.

Although the data were generated in cell culture and in a mouse xenograft model, the findings could point to a new target for cancer treatment, the authors wrote in The Journal of Clinical Investigation.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: genome sequencing study of Yakutian horses, tardigrade genome, and more.

A guest post at Retraction Watch discusses what funders can do to improve research reproducibility.

Researchers report in Nature this week that farming led to genomic adaptations in humans.

The FDA argues that it needs to evaluate the safety and efficacy of laboratory-developed tests, a proposal that divides Republicans.

Sponsored by
HTG Molecular

This webinar will discuss potential clinical applications for miRNA signatures and a novel, extraction-free miRNA profiling technology for advancing biomarker discovery.